The economic burden of individuals living with generalized myasthenia gravis and facing social determinants of health challenges

Objective: Better understanding the impact of social determinants of health (SDOH) barriers from the patient perspective is crucial to improve holistic patient support in generalized myasthenia gravis (gMG), a rare autoimmune disorder with high disease and treatment burden. The objective of this study was to identify economic challenges experienced by individuals living with gMG and SDOH barriers to better address current unmet needs. Methods: Adults (18-75 years) living with gMG and experiencing SDOH barriers in the United States were recruited to a mixed-methods study including qualitative interviews and a web-based quantitative survey. Quotas were implemented to include a balanced spread of baseline demographic categories including insurance type, living environment, and employment status among the study sample. Direct and indirect economic challenges were identified by degree of concern. Results: The survey was completed by 38 individuals living with gMG, the majority of whom were enrolled in public insurance and not employed. The most commonly reported major economic concerns were managing funds for emergency care (66%), loss of income (61%), and non-medical expenses (58%), highlighting the diversity of economic challenges. Individuals who were using public insurance plans, living in non-urban environments, and unemployed experienced pronounced challenges around managing non-medical costs and accessing government assistance. Conclusion: Both direct and indirect costs were emphasized as major concerns among individuals living with gMG and SDOH barriers. Increasing access to relevant, personalized, and holistic resources, including care management, should be prioritized to improve disease management and outcomes for individuals living with gMG

Business · Economic growth · Economics · Environmental health · Health care · Indirect costs · Public health · Social determinants of health · Adrenal Hormones and Disorders · Coagulation, Bradykinin, Polyphosphates, and Angioedema · Medicine · Myasthenia Gravis and Thymoma · Nursing · Gerontology

• Racial disparities in acute care utilization among individuals with myasthenia gravis

  Open Access•Cynthia Z Qi, Cynthia Qi et al.•Frontiers in Public Health•2025

  Incluir item

• Social Determinants of Health and Diabetes

  Open Access•Felicia Hill-Briggs, Felicia Hill‐Briggs et al.•Diabetes Care•2021

  Incluir item

• Socio-Economic Burden of Myasthenia Gravis

  Open Access•Valentina Ignatova, Kostadin Kostadinov et al.•Frontiers in Public Health•2022

  Incluir item

• Impact of social determinants of health on individuals living with generalized myasthenia gravis and implications for patient support programs

  Open Access•Tom Hughes, Ashley Anderson et al.•Frontiers in Public Health•2023

  Incluir item

• The role of advocacy and empowerment in shaping service development for families raising children with developmental disabilities

  Open Access•Zsófia Szlamka, Bethlehem Tekola et al.•Health Expectations•2022

  Incluir item

• Interventions to reduce cancer screening inequities

  Open Access•Afua Richardson-Parry, Carole Baas et al.•International Journal for Equity…•2023

  Incluir item

• The Cost of Implementing and Sustaining the COMprehensive Post-Acute Stroke Services Model

  William S Bayliss, Cheryl D Bushnell et al.•Medical Care•2021

  Incluir item